Robert Half
RHI
33.95
+0.28
+0.83%
Robert Half
US · RHI
#2373 by market cap
Listed 1970
33.95
+0.28
+0.83%
Live - 5344 symbols - heartbeat 251s ago
· 2026-10-07 19:54
After-hours
33.95
0.00%
- Market cap
- 3.48B
- P/E (TTM)i
- 29.52
- P/Bi
- 2.88
- EPSi
- 1.33
- Div yieldi
- 6.95%
- 52W posi
- 51%
Reader sentiment
Are you bullish or bearish on RHI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.60, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -7.20% YoY
Margins
- Gross margin
- 37.23%
- Operating margin
- 1.42%
- Net margin
- 2.47%
Key ratios & quality
- Altman Z-Scorei
- 3.60
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.80B | 6.07B | 5.11B | 6.46B | 7.24B | 6.39B | 5.80B | 5.38B |
| Gross profit | 2.41B | 2.53B | 2.01B | 2.70B | 3.09B | 2.58B | 2.25B | 2.00B |
| Selling & admin expenses | 1.81B | 1.96B | 1.67B | 1.95B | 2.12B | 2.11B | 2.01B | 1.93B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 598.71M | 565.47M | 345.35M | 742.51M | 975.09M | 464.59M | 241.47M | 76.46M |
| Pretax profit | 591.60M | 625.52M | 421.88M | 803.78M | 896.96M | 576.58M | 357.67M | 194.35M |
| Tax | 157.31M | 171.08M | 115.61M | 205.15M | 239.04M | 165.44M | 106.07M | 61.36M |
| Net profit | 434.29M | 454.43M | 306.28M | 598.63M | 657.92M | 411.15M | 251.60M | 132.99M |
| Basic EPS | 4 | 4 | 3 | 5 | 6 | 4 | 2 | 1 |
| Diluted EPS | 3.57 | 3.90 | 2.70 | 5.36 | 6.03 | 3.88 | 2.44 | 1.33 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.35B | 1.37B | 1.35B | 1.30B | 1.30B | 1.34B |
| Gross profit | 499.05M | 509.47M | 504.23M | 489.56M | 479.91M | 474.03M |
| Selling & admin expenses | 460.16M | 507.93M | 490.64M | 467.11M | 443.00M | 536.33M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 38.88M | 1.54M | 13.59M | 22.45M | 36.91M | -62.30M |
| Pretax profit | 22.28M | 61.43M | 63.72M | 46.92M | 31.44M | 40.59M |
| Tax | 4.93M | 20.47M | 20.80M | 15.16M | 17.65M | 14.27M |
| Net profit | 17.35M | 40.97M | 42.92M | 31.76M | 13.79M | 26.32M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.17 | 0.41 | 0.43 | 0.32 | 0.14 | 0.26 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.47B | 1.63B | 1.84B | 2.27B | 2.29B | 2.30B | 2.13B | 2.12B |
| Cash & ST investments | 276.58M | 270.48M | 574.43M | 619.00M | 658.63M | 731.74M | 537.58M | 464.44M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.90B | 2.31B | 2.56B | 2.95B | 2.96B | 3.01B | 2.85B | 2.86B |
| Total current liabilities | 819.54M | 940.69M | 1.05B | 1.36B | 1.22B | 1.24B | 1.29B | 1.38B |
| Short-term debt | 200.00K | 71.63M | 78.84M | 83.79M | 86.08M | 80.46M | 64.62M | 69.79M |
| Long-term debt | 457.00K | 239.00K | -- | -- | -- | -- | -- | -- |
| Total liabilities | 839,899,000.00 | 1,167,725,000.00 | 1,352,135,000.00 | 1,571,308,000.00 | 1,395,930,000.00 | 1,422,438,000.00 | 1,476,402,000.00 | 1,580,419,000.00 |
| Total equity | 1.06B | 1.14B | 1.21B | 1.38B | 1.57B | 1.59B | 1.38B | 1.28B |
| Retained earnings | 0 | 36.07M | 29.94M | 167.66M | 318.51M | 266.17M | 24.89M | 0 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.97B | 2.08B | 2.12B | 2.12B | 1.97B | 2.14B |
| Cash & ST investments | 342.47M | 380.55M | 365.29M | 464.44M | 278.39M | 324.71M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 2.70B | 2.83B | 2.85B | 2.86B | 2.70B | 2.86B |
| Total current liabilities | 1.19B | 1.32B | 1.36B | 1.38B | 1.27B | 1.46B |
| Short-term debt | 67.25M | 69.28M | 69.74M | 69.79M | 69.16M | 66.54M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 1,383,731,000.00 | 1,520,278,000.00 | 1,560,286,000.00 | 1,580,419,000.00 | 1,472,471,000.00 | 1,650,840,000.00 |
| Total equity | 1.31B | 1.31B | 1.29B | 1.28B | 1.23B | 1.21B |
| Retained earnings | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 572.32M | 519.63M | 596.53M | 603.14M | 683.75M | 636.88M | 410.47M | 319.97M |
| Depreciation & amortization | 65.95M | 69.25M | 81.90M | 82.47M | 77.99M | 98.97M | 89.32M | 81.63M |
| Free cash flow | 529.84M | 460.17M | 563.15M | 566.53M | 622.63M | 591.01M | 354.15M | 266.81M |
| Dividends paid | -136.42M | -145.63M | -155.94M | -170.61M | -189.29M | -205.91M | -220.41M | -238.22M |
| Stock buybacks / issuance | -353.51M | -277.54M | -159.17M | -287.74M | -319.90M | -254.63M | -276.03M | -92.09M |
| Ending cash balance | 276.58M | 270.48M | 574.43M | 619.00M | 658.63M | 731.74M | 537.58M | 464.44M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -59.35M | 119.38M | 77.40M | 182.53M | -112.34M | 108.70M |
| Depreciation & amortization | 21.62M | 21.09M | 19.77M | 19.15M | 18.67M | 18.34M |
| Free cash flow | -71.74M | 104.20M | 63.57M | 170.79M | -120.83M | 101.54M |
| Dividends paid | -61.29M | -59.37M | -58.89M | -58.67M | -61.72M | -59.12M |
| Stock buybacks / issuance | -49.94M | -21.06M | -21.07M | -24.00K | -6.12M | -618.00K |
| Ending cash balance | 342.47M | 380.55M | 365.29M | 464.44M | 278.39M | 324.71M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 40.05 | 41.18 | 26.08 | 46.29 | 44.61 | 26.05 | 16.96 | 10.02 |
| ROA %i | 23.04 | 21.57 | 12.58 | 21.73 | 22.24 | 13.76 | 8.58 | 4.66 |
| ROIC %i | 39.73 | 36.33 | 20.87 | 37.95 | 37.77 | 21.67 | 13.72 | 7.97 |
| 5-year avg ROE %i | 33.54 | 35.34 | 33.34 | 36.02 | 39.64 | 36.84 | 32.00 | 28.79 |
| EBIT margin %i | 10.12 | 10.21 | 6.76 | 11.49 | 13.47 | 7.27 | 4.17 | 1.42 |
| FCF / sales %i | 9.13 | 7.58 | 11.02 | 8.77 | 8.60 | 9.25 | 6.11 | 4.96 |
| Current ratioi | 1.80 | 1.73 | 1.76 | 1.67 | 1.88 | 1.86 | 1.66 | 1.53 |
| Quick ratioi | 1.31 | 1.17 | 1.23 | 1.18 | 1.38 | 1.29 | 1.02 | 0.88 |
| Debt / assetsi | 0.03 | 11.85 | 11.84 | 8.98 | 8.02 | 8.03 | 8.18 | 8.60 |
| LT debt / equityi | 0.04 | 17.68 | 18.57 | 13.13 | 9.68 | 10.16 | 12.26 | 13.77 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 4.42 | 4.98 | -1.01 | 3.66 | 6.02 | 7.76 | -3.56 | -9.42 |
| Net income CAGR (3Y) %i | 6.67 | 9.79 | 1.77 | 11.29 | 13.13 | 10.31 | -25.09 | -41.31 |
| FCF CAGR (3Y) %i | 13.42 | 8.61 | 10.96 | 2.26 | 10.60 | 1.62 | -14.50 | -24.61 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 14.49 | 12.75 | 11.27 | 10.02 | 10.17 | 9.11 |
| ROA %i | 7.35 | 6.17 | 5.34 | 4.66 | 4.79 | 4.03 |
| ROIC %i | 11.55 | 10.18 | 9.02 | 7.97 | 8.06 | 7.19 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.22 | 2.97 | 2.17 | 1.42 | 1.40 | 0.20 |
| FCF / sales %i | 5.47 | 5.11 | 4.33 | 4.96 | 4.09 | 4.06 |
| Current ratioi | 1.65 | 1.57 | 1.55 | 1.53 | 1.55 | 1.47 |
| Quick ratioi | 0.95 | 0.91 | 0.88 | 0.88 | 0.83 | 0.79 |
| Debt / assetsi | 9.00 | 8.60 | 8.46 | 8.60 | 9.32 | 8.42 |
| LT debt / equityi | 13.36 | 13.29 | 13.30 | 13.77 | 14.85 | 14.43 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Contract talent solutions is the largest reported line at 55.93% of revenue, across 3 reported segments.
- Protiviti follows at 35.24%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Contract talent solutions55.93%
Protiviti35.24%
Permanent placement talent solutions8.83%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.